Mahesh,
I admire your enthusiasm for Syngene.
I have few questions though, would be great if you can answer them –
1) What is it that can go wrong for Syngene? I don’t see anything negative listed in the thread and that kind of scares me.
2) In the entire thread, I only see financials being talked about (P/E, ROE, ROCE, Capex, EV etc.) but not enough discussion on what is company “actually” doing at the next level of detail. What are the name of the molecules? Who are their customers? Do we know which area the molecules are in (Dermatology? Paediatric? etc.)
Thanks,
Rupesh
P. S. Not invested
Subscribe To Our Free Newsletter |